- Home
- MDLN
as of 02-09-2026 3:58pm EST
$47.26
$0.04
-0.08%
Medline Inc provides medical-surgical products and supply chain solutions for various healthcare settings. Its offerings include med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. It serves hospitals, surgery centers, physician offices, and post-acute care facilities, supporting patient care needs. The company operates in two segments: Medline Brand and Supply Chain Solutions. The company's revenues are generated principally from the sale of its surgical products.
| Founded: | 1966 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 38.3B | IPO Year: | 2025 |
| Target Price: | $47.74 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 23 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.07 | EPS Growth: | 441.66 |
| 52 Week Low/High: | $34.89 - $47.99 | Next Earning Date: | 02-25-2026 |
| Revenue: | $27,429,000,000 | Revenue Growth: | 18.07% |
| Revenue Growth (this year): | 12.59% | Revenue Growth (next year): | 8.52% |
| P/E Ratio: | 653.09 | Index: | N/A |
| Free Cash Flow: | 1.0B | FCF Growth: | -27.93% |
Stock Insider Trading Activity of Medline Inc. Class A Common Stock (MDLN)
Mozart Aggregator II LP
Sell
10% Owner
MDLN Dec 18, 2025
Avg Cost/Share
$28.37
Shares
13,462,600
Total Value
$381,911,075.58
Owned After
143,187,216
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Mozart Aggregator II LP | MDLN | 10% Owner | Dec 18, 2025 | Sell | $28.37 | 13,462,600 | $381,911,075.58 | 143,187,216 |
Latest Medline Inc. Class A Common Stock News
MDLN Breaking Stock News: Dive into MDLN Ticker-Specific Updates for Smart Investing
Motley Fool
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
TD Cowen Initiates Coverage on Medline With Buy Rating, $46 Price Target
📈
AI Sentiment
Highly Positive
8/10
Compare MDLN vs Leading Stocks
See how MDLN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDLN Medline Inc. Class A Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.